Roche’s virtual analyst event during ESMO IO
Roche has hosted a virtual event on Friday, 10 December 2021.
| Agenda | |
|---|---|
| Welcome | Karl Mahler, Head of Investor Relations |
| CITYSCAPE updated analysis: Tiragolumab + Tecentriq in 1L NSCLC | Raymond Meng, M.D., Ph.D. - Global Development Leader Tiragolumab |
| Tiragolumab development overview | Heather Stevens, MBA, MPH - Life Cycle Leader, Tiragolumab |
| Q&A |
Webinar Replay
Investors